- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Celebrating Innovation: Prix Galien Photo Gallery
Pharmaceutical Executive
Photos from the awards ceremony of the first US Prix Galien, September 25, 2007 in New York City.
The Prix Galien Awards were established more than 30 years ago in France to honor research innovation within the pharmaceutical industry. Since their creation, the awards have expanded to other countries around the globe. This year marked the first time the Prix Galien Awards honored American innovation. The black-tie event—held on Sept. 25, 2007, at New York City's swank Cipriani—was truly a star-studded affair, presided over by television personality Charlie Rose and featuring a special appearance by author and Nobel Peace Prize laureate Elie Wiesel. Medals were awarded by an esteemed panel of judges, including the six Nobel laureates in attendance. Pfizer's Chantix and Merck's Januvia took home awards for best pharmaceutical product, and Abbott Labs' Humira and Merck's Gardasil won in the biotech class—but a good time was had by all.
Johnson & Johnson Seeks FDA Approval for Subcutaneous Tremfya Regimen for Ulcerative Colitis
November 22nd 2024Johnson & Johnson has submitted a supplemental Biologics License Application to the FDA for a subcutaneous induction regimen of Tremfya for adults with moderately to severely active ulcerative colitis based on positive Phase III ASTRO trial results.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
